These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 16966546)

  • 1. Associations between white matter lesions, cerebrovascular risk factors, and low CSF Abeta42.
    Stenset V; Johnsen L; Kocot D; Negaard A; Skinningsrud A; Gulbrandsen P; Wallin A; Fladby T
    Neurology; 2006 Sep; 67(5):830-3. PubMed ID: 16966546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. White matter lesion severity is associated with reduced cognitive performances in patients with normal CSF Abeta42 levels.
    Stenset V; Hofoss D; Johnsen L; Skinningsrud A; Berstad AE; Negaard A; Reinvang I; Gjerstad L; Fladby T
    Acta Neurol Scand; 2008 Dec; 118(6):373-8. PubMed ID: 18510598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.
    Tapiola T; Alafuzoff I; Herukka SK; Parkkinen L; Hartikainen P; Soininen H; Pirttilä T
    Arch Neurol; 2009 Mar; 66(3):382-9. PubMed ID: 19273758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter lesion load increases the risk of low CSF Aβ42 in apolipoprotein E-ɛ4 carriers attending a memory clinic.
    Stenset V; Hofoss D; Johnsen L; Berstad AE; Negaard A; Skinningsrud A; Gjerstad L; Fladby T
    J Neuroimaging; 2011 Apr; 21(2):e78-82. PubMed ID: 19888930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. White matter lesions on magnetic resonance imaging and their relationship with vascular risk factors in memory clinic attenders.
    Lazarus R; Prettyman R; Cherryman G
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):274-9. PubMed ID: 15717341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of Alzheimer's disease using the CSF Abeta42/Abeta40 ratio in patients with mild cognitive impairment.
    Hansson O; Zetterberg H; Buchhave P; Andreasson U; Londos E; Minthon L; Blennow K
    Dement Geriatr Cogn Disord; 2007; 23(5):316-20. PubMed ID: 17374949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebral white matter lesions in patients with dementia - from MCI to severe Alzheimer's disease.
    Targosz-Gajniak M; Siuda J; Ochudło S; Opala G
    J Neurol Sci; 2009 Aug; 283(1-2):79-82. PubMed ID: 19268974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSF biomarkers in relationship to cognitive profiles in Alzheimer disease.
    van der Vlies AE; Verwey NA; Bouwman FH; Blankenstein MA; Klein M; Scheltens P; van der Flier WM
    Neurology; 2009 Mar; 72(12):1056-61. PubMed ID: 19307538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of low plasma Abeta42/Abeta40 ratios with increased imminent risk for mild cognitive impairment and Alzheimer disease.
    Graff-Radford NR; Crook JE; Lucas J; Boeve BF; Knopman DS; Ivnik RJ; Smith GE; Younkin LH; Petersen RC; Younkin SG
    Arch Neurol; 2007 Mar; 64(3):354-62. PubMed ID: 17353377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low serum potassium in mid life associated with decreased cerebrospinal fluid Abeta42 in late life.
    Mielke MM; Zandi PP; Blennow K; Gustafson D; Sjögren M; Rosengren L; Skoog I
    Alzheimer Dis Assoc Disord; 2006; 20(1):30-6. PubMed ID: 16493233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease.
    Schoonenboom NS; van der Flier WM; Blankenstein MA; Bouwman FH; Van Kamp GJ; Barkhof F; Scheltens P
    Neurobiol Aging; 2008 May; 29(5):669-75. PubMed ID: 17208336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
    Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. No association of CSF biomarkers with APOEepsilon4, plaque and tangle burden in definite Alzheimer's disease.
    Engelborghs S; Sleegers K; Cras P; Brouwers N; Serneels S; De Leenheir E; Martin JJ; Vanmechelen E; Van Broeckhoven C; De Deyn PP
    Brain; 2007 Sep; 130(Pt 9):2320-6. PubMed ID: 17586559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oligomerization partially explains the lowering of Abeta42 in Alzheimer's disease cerebrospinal fluid.
    Englund H; Degerman Gunnarsson M; Brundin RM; Hedlund M; Kilander L; Lannfelt L; Pettersson FE
    Neurodegener Dis; 2009; 6(4):139-47. PubMed ID: 19521063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-brain barrier permeability correlates with medial temporal lobe atrophy but not with amyloid-beta protein transport across the blood-brain barrier in Alzheimer's disease.
    Matsumoto Y; Yanase D; Noguchi-Shinohara M; Ono K; Yoshita M; Yamada M
    Dement Geriatr Cogn Disord; 2007; 23(4):241-5. PubMed ID: 17310121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. White matter hyperintensities and cognitive dysfunction in Alzheimer disease.
    Heo JH; Lee ST; Kon Chu ; Park HJ; Shim JY; Kim M
    J Geriatr Psychiatry Neurol; 2009 Sep; 22(3):207-12. PubMed ID: 19433863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The relationship between cerebrospinal fluid biomarkers and depression in elderly women.
    Gudmundsson P; Skoog I; Waern M; Blennow K; Pálsson S; Rosengren L; Gustafson D
    Am J Geriatr Psychiatry; 2007 Oct; 15(10):832-8. PubMed ID: 17911361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subjective cognitive failures and hippocampal volume in elderly with white matter lesions.
    van Norden AG; Fick WF; de Laat KF; van Uden IW; van Oudheusden LJ; Tendolkar I; Zwiers MP; de Leeuw FE
    Neurology; 2008 Oct; 71(15):1152-9. PubMed ID: 18838662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study.
    Godin O; Maillard P; Crivello F; Alpérovitch A; Mazoyer B; Tzourio C; Dufouil C
    Cerebrovasc Dis; 2009; 28(2):177-84. PubMed ID: 19556771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma Abeta levels do not reflect brain Abeta levels.
    Freeman SH; Raju S; Hyman BT; Frosch MP; Irizarry MC
    J Neuropathol Exp Neurol; 2007 Apr; 66(4):264-71. PubMed ID: 17413317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.